Stay updated on KRAS G12C Inhibitor Clinical Trial
Sign up to get notified when there's something new on the KRAS G12C Inhibitor Clinical Trial page.

Latest updates to the KRAS G12C Inhibitor Clinical Trial page
- Check7 days agoChange DetectedThe clinical trial was terminated for business reasons, with the record explicitly noting that the decision was not based on safety concerns. Its latest record version also updates study identification, status, description, outcomes, interventions, and contact/location information.SummaryDifference0.6%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check21 days agoChange DetectedA banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check28 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check49 days agoChange DetectedTwo new history entries (versions 54 and 55) were added, introducing updates to the Study Status and Contacts/Locations sections; an older entry from 2026-08-27 was removed.SummaryDifference0.4%

Stay in the know with updates to KRAS G12C Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KRAS G12C Inhibitor Clinical Trial page.